abstract |
The present disclosure relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof:nâ–ˇnWherein m, p, A, Ar1, Ar2, Ar3, R1, R2, and R3 are as in the present specificationnDefined. The compound of formula (I) can be used as a CGRP antagonist and can be used for treatmentnMigraine. |